Transcatheter aortic valve implantation (TAVI) is now an established treatment option for elderly patients with severe ...

Traditional operative risk calculators, such as the European System for Cardiac Operative Risk Evaluation II (EuroSCORE II), ...

Permanent pacemaker rates were nearly 18% at 30 days but came down as sites gained experience with the new device.

About this study The objective of ENVISION is to evaluate the safety and effectiveness of the Navitor Transcatheter Aortic Valve Implantation (TAVI) System for treating patients with symptomatic, ...

In EARLY TAVR, intervention improved outcomes over waiting in patients with class II or no indications for AVR consideration.

Medtronic's margin inflection from the Diabetes spin-off and strong innovation pipeline support major upside. Find out why ...

Newark, N.J.-based University Hospital’s Structural Heart Program completed its 100th transcatheter aortic valve replacement procedure. Each procedure is performed by a multidisciplinary team, ...

HonorHealth Research Institute clinical trial, using non-surgical techniques, showed 86% of patients with a type of usually ...

Patients received a new treatment for heart valve disease, which did not require riskier open-heart surgery or travel to London.Five people from Cambridgeshire, Essex, Hertfordshire, Peterborough and ...

NEW YORK CITY -- The newer Navitor looked increasingly viable as a transcatheter aortic valve replacement (TAVR) system, ...

Calcific Aortic Stenosis in the Elderly: A Brief Overview Neil Sawhney, MD, Alborz Hassankhani, MD, PhD, Barry H. Greenberg, MD Disclosures Am J Geriatr Cardiol. 2003;12 (3) Conclusion ...

Background Bicuspid aortic regurgitation (AR) is common in younger patients who often do not meet guideline-based criteria for aortic valve (AV) surgery at diagnosis. However, identifying early ...